Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials

Published:2015-09 Issue:9 Volume:128 Page:1007-1014.e2
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Renda Giulia,di Nicola Marta,De Caterina Raffaele^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel;Husted;Thromb Haemost,2014

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation;Neurology, Neuropsychiatry, Psychosomatics;2022-12-19

2. Oral Anticoagulant Use and Appropriateness in Elderly Patients with Atrial Fibrillation in Complex Clinical Conditions: ACONVENIENCE Study;Journal of Clinical Medicine;2022-12-14

3. Net clinical benefit of anticoagulant therapy from a neurologist's perspective: A review;Consilium Medicum;2022-02-15

4. Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice;Terapevticheskii arkhiv;2021-10-15

5. Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality;Scientific Reports;2021-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3